Frequent Occurrence of Hypogonadotropic Hypogonadism in Type 2 Diabetes
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Type 2 diabetes is associated with lower total testosterone (T) levels in cross-sectional studies. However, it is not known whether the defect is primary or secondary. We investigated the prevalence of hypogonadism in type 2 diabetes by measuring serum total T, free T (FT), SHBG, LH, FSH, and prolactin (PRL) in 103 type 2 diabetes patients. FT was measured by equilibrium dialysis. FT was also calculated by using T and SHBG (cFT). Hypogonadism was defined as low FT or cFT. The mean age was 54.7 +/- 1.1 yr, mean body mass index (BMI) was 33.4 +/- 0.8 kg/m(2), and mean HbA1c was 8.4 +/- 0.2%. The mean T was 12.19 +/- 0.50 nmol/liter (351.7 +/- 14.4 ng/dl), SHBG was 27.89 +/- 1.65 nmol/liter, and FT was 0.250 +/- 0.014 nmol/liter. Thirty-three percent of patients were hypogonadal. LH and FSH levels were significantly lower in the hypogonadal group compared with patients with normal FT levels (3.15 +/- 0.26 vs. 3.91 +/- 0.24 mIU/ml for LH and 4.25 +/- 0.45 vs. 5.53 +/- 0.40 mIU/ml for FSH; P < 0.05). There was a significant inverse correlation of BMI with FT (r = -0.382; P < 0.01) and T (r = -0.327; P < 0.01). SHBG correlated inversely with BMI (r = -0.267; P < 0.05) but positively with age (r = 0.538; P < 0.001) and T (r = 0.574; P < 0.001). FT correlated strongly with cFT (r = 0.919; P < 0.001) but not with SHBG. LH levels correlated positively with FT (r = 0.287; P < 0.05). We conclude that hypogonadotropic hypogonadism occurs commonly in type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, Dhindsa et al. (9) demonstrated that 33% of men with type 2 diabetes had significantly lower levels of free testosterone measured by equilibrium dialysis, which is the widely accepted most clinically relevant assay for free testosterone.”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [9]
In the citing paper
“Furthermore, it has been reported that testosterone levels are lower in diabetic men compared with nondiabetic subjects (6 -9).”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [9]
In the citing paper
“A recent study has demonstrated that free testosterone levels, which are independent of SHBG, are low in one-third of diabetic men (9).”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [9]
In the citing paper
“Most of the studies in diabetic men have defined hypogonadism solely on the basis of testosterone levels (9).”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [9]
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824 · cited 1×
“(12) and using a computer program and web site address supplied by Dr.”
MethodLongitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760 · cited 11×
“We compared the prevalence of hypogonadism in our study (using the same criteria as BLSA) across various age ranges with the prevalence from BLSA.”
ResultInfluentialRole of Brain Insulin Receptor in Control of Body Weight and Reproduction
Brüning, J. C., Gautam, D., Burks, D. J., Gillette, J., Schubert, M., Orban, P. C., Klein, R., Krone, W., Müller-Wieland, D., & Kahn, C. R. (2000) · Science · doi:10.1126/science.289.5487.2122 · Cited by 2,235
Feldman, H. A., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., & McKinlay, J. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8201 · Cited by 1,861 · cited 3×
“In the BLSA, the presence of cancer was associated with a greater decline in T levels than that observed with aging alone (23).”
BackgroundDUNN, J. F., NISULA, B. C., & RODBARD, D. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-1-58 · Cited by 1,238 · cited 1×
“In the blood of normal men, 44% of total T is bound to SHBG, 2% is unbound [free T (FT)], and 54% circulates bound to albumin and other proteins (9).”
BackgroundGRAY, A., FELDMAN, H. A., MCKINLAY, J. B., & LONGCOPE, C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1016 · Cited by 1,118 · cited 1×
“PRL levels remain constant or either increase or decrease slightly with age (18, 23).”
BackgroundTestosterone dose-response relationships in healthy young men
Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Bhasin, D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., Dzekov, C., et al. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1172 · Cited by 967 · cited 1×
“Serum T levels in the lower range of normal are able to maintain aspects of sexual functions, but muscle strength, muscle size, and fat-free mass increase progressively in a dose-dependent fashion with increase in circulating T concentrations even within the normal range (39, 40).”
BackgroundMorley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., Morley, P. M. K., Stauber, P. M., Vellas, B., Baumgartner, R. N., & Garry, P. J. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90057-3 · Cited by 830 · cited 2×
“The increase in LH does not correlate with the decrease in T, suggesting an age-related alteration in this feedback mechanism (24, 25).”
Background
Cited by
Items 401–500 of 637
Use of Testosterone Replacement Therapy in Patients with Prostate Cancer
Dorff, T. B., & Vogelzang, N. J. (2011) · Current Urology Reports · doi:10.1007/s11934-011-0176-2 · Cited by 8
“There is an increased risk of developing diabetes due to hypogonadism induced by androgen deprivation therapy [6], and cross-sectional data document a high rate of hypogonadism among patients with diabetes [ 7 ].”
BackgroundLi, F., Wang, C., Huang, J., Yang, W., Lan, B., Ding, C., Huang, C., Lao, G., Sun, K., Li, L., et al. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13513 · Cited by 7
Corona, G., Rastrelli, G., Ricca, V., & Maggi, M. (2010) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2010.048 · Cited by 7
Obesity and Testicular Function
Ilacqua, A., Francomano, D., & Aversa, A. (2014) · Springer eBooks · doi:10.1007/978-3-319-09045-0_10 · Cited by 9
Diabetes, Bone Density, and Fractures
Shivaswamy, V. (2012) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.s1-004 · Cited by 7
“showed that hypogonadism occurred in as many as one-third of men with type 2 diabetes, irrespective of the glycemic control, duration of disease, and the presence of complications of diabetes or obesity [48].”
BackgroundSex hormones, obesity and type 2 diabetes-is there a link?
Gambineri, A. (2018) · Endocrine Abstracts · doi:10.1530/endoabs.56.s18.1 · Cited by 7
The occurrence of hypogonadotropic hypogonadism in Chinese men with type 2 diabetes
Zhou, Y., Tian, R., Wang, X., Sun, J., Zhu, L., & An, X. (2022) · Clinical Endocrinology · doi:10.1111/cen.14680 · Cited by 6
“225 nmol/L as previously reported.(19,22) Based on the TT and cFT threshold values, the subjects were divided to hypogonadal and eugonadal groups.”
BackgroundMethodResultInfluentialDhindsa, S., Irwig, M. S., & Wyne, K. L. (2018) · Endocrine Practice · doi:10.4158/ep-2017-0131 · Cited by 7
Self-citationNutritional Treatment of Diabetic Foot Ulcers - A Key to Success
Tatti, P., & Barber, A. E. (2011) · InTech eBooks · doi:10.5772/27418 · Cited by 7
Specific features of urogenital disorders in patents with diabetes mellitus
Rozhivanov, R. V., Akimova, A. N., Dubsky, S., Курбатов, Д. Г., & Dedov, I. I. (2009) · Diabetes Mellitus · doi:10.14341/2072-0351-5396 · Cited by 6
Mollace, V., Malara, N., Gratteri, S., Palma, E., Zappia, L., Costa, N., Rosano, G., & Paone, S. (2016) · PharmaNutrition · doi:10.1016/j.phanu.2015.11.006 · Cited by 6
Rabijewski, M., Papierska, L., & Piątkiewicz, P. (2016) · Journal of Diabetes Research · doi:10.1155/2016/1747261 · Cited by 8
Ali, T. M., & Askary, A. E. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.06.022 · Cited by 6
Anupam, B., Shivaprasad, C., Atluri, S., Aiswarya, Y., Gautham, K., Barure, R., & Shah, K. (2019) · International Journal of Impotence Research · doi:10.1038/s41443-019-0144-9 · Cited by 7
“TT and FT (both calculated and measured by equilibrium dialysis) declined significantly with an increase in BMI as reported by earlier studies [5, 8].”
BackgroundMethodResultInfluentialLower circulating kisspeptin and primary hypogonadism in men with type 2 diabetes
Asare‐Anane, H., Ofori, E. K., Kwao‐Zigah, G., Ateko, R. O., Annan, B., Adjei, A. B., & Quansah, M. (2019) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70 · Cited by 6
Stanciu, I., Abboud, A., Kellman, W., Williams, D. D., & Azad, N. (2010) · The Open Andrology Journal · doi:10.2174/1876827x01002010006 · Cited by 6
ABCD position statement on the management of hypogonadal males with type 2 diabetes
Dhatariya, K., Nagi, D. K., & Jones, T. H. (2010) · Practical Diabetes · doi:10.1002/pdi.1535 · Cited by 10
Hypogonadism among Jordanian men with type 2 diabetes: Prevalence and associated factor
Hayek, A. A., Khader, Y. S., Jafal, S., Khawaja, N. M., & Ajlouni, K. M. (2011) · International Journal of Diabetes Mellitus · doi:10.1016/j.ijdm.2011.01.003 · Cited by 7
“Most studies among men with diabetes had defined hypogonadism solely on the basis of testosterone levels [5].”
BackgroundResultTestosterone Therapy and Glucose Homeostasis in Men with Testosterone Deficiency (Hypogonadism)
Saad, F. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-70178-3_23 · Cited by 8
“A considerable body of evidence exists demonstrating the link between reduced T levels and diabetes (Kapoor et al. 2007; Dhindsa et al. 2004; Grossmann et al. 2008; Haffner et al. 1996; Oh et al. 2002; Stellato et al. 2000; Lakshman et al. 2010; Ho et al. 2013).”
BackgroundThe role of accurate testosterone testing in the treatment and management of male hypogonadism
Dobs, A. S. (2008) · Steroids · doi:10.1016/j.steroids.2008.06.007 · Cited by 10
Overt hypogonadism is a cardiovascular risk factor in type 2 diabetic males: An observational study
Oğuz, A., Şahin, M., Ülgen, C., Uyan, M., & Gül, K. (2021) · Andrologia · doi:10.1111/and.14271 · Cited by 5
Role of Androgens in Cardiovascular Diseases in Men: A Comprehensive Review
Mukherjee, D., Sen, K., Gupta, S., Chowdhury, P. D., Majumder, S., & Guha, P. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.85852 · Cited by 5
Castro, M. A., Mariño‐Sánchez, F., Fernández, A. G., Cancela, A. A., & Berrocal, V. R. (2021) · Neurocirugía · doi:10.1016/j.neucir.2021.07.004 · Cited by 5
Hypogonadism in Systemic Diseases
Rochira, V. (2017) · Endocrinology · doi:10.1007/978-3-319-44441-3_28 · Cited by 6
Sexual Dysfunction in Diabetic Patients: Τhe Role of Advanced Glycation End Products
Peppa, Μ., & Manta, A. (2023) · Current Diabetes Reviews · doi:10.2174/1573399819666230407095522 · Cited by 7
Body adipose distribution among patients with type 2 diabetes mellitus
Xie, L., & Cheng, M. (2012) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2012.09.003 · Cited by 5
“[50] Dhindsa S, Prabhakar S, Sethi M, Bandyopadhyay A, Chaudhuri A, Dandona P.”
BackgroundWen, T., & Kang, D. (2017) · Biomedical Research-tokyo · Cited by 5
Al‐Fartosy, A. J. M., & Mohammed, I. M. (2017) · Advances in Biochemistry · doi:10.11648/j.ab.20170505.11 · Cited by 11
Intranasal Insulin Administration Does Not Affect LH Concentrations in Men with Diabetes
Dhindsa, S., Chemitiganti, R., Ghanim, H., Santiago, E., Haider, A., Natalia, C., Mok, M., McKee, A. M., & Dandona, P. (2018) · International Journal of Endocrinology · doi:10.1155/2018/6170154 · Cited by 5
Self-citationQuang, L. M., & Kalhan, A. (2018) · British Journal of Diabetes · doi:10.15277/bjd.2018.192 · Cited by 5
Serum High-Sensitivity C-Reactive Protein and Endogenous Sex Hormones in Diabetic Men
Alaaraji, S. F. T. (2016) · Journal of Biotechnology Research Center · doi:10.24126/jobrc.2016.10.1.463 · Cited by 5
“Testosterone deficiency is common in men with type 2 diabetes [2], in whom it may contribute to impaired performance, mood, and libido [3].”
BackgroundMorbidity and mortality in men: Role of androgens
Fallara, G., Pozzi, E., Corsini, C., Belladelli, F., Boeri, L., Capogrosso, P., Montorsi, F., & Salonia, A. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101662 · Cited by 5
Testosterone replacement therapy: What to look for, when to treat
Cawley, M. A. (2009) · The Nurse Practitioner · doi:10.1097/01.npr.0000360150.79515.a8 · Cited by 5
Hypogonadism in Nigerian men with type 2 diabetes mellitus
Onung, S. I., Young, E. E., Ugwu, T. E., & Fasanmade, O. A. (2016) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-016-0481-x · Cited by 8
Allan, C. A., & McLachlan, R. I. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00139-8 · Cited by 5
Cai, L., Xie, H., Li, W., Chen, C., Li, T., Xu, L., Mao, Y., Liang, J., Wen, J., & Chen, G. (2025) · Endocrine · doi:10.1007/s12020-025-04199-7 · Cited by 5
“Furthermore, sedentary behavior is closely linked to insulin resistance and metabolic syndrome [32, 33].”
Amodeo, A., Cangiano, B., Duca, N. D., Chilà, A., Musolino, A., Garavaglia, I., Donne, E. D., Casiraghi, A., Manzini, C., Vezzoli, V., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf635 · Cited by 4
Patients with testosterone deficiency syndrome and type 2 diabetes.
Corona, G., & Maggi, M. (2013) · PubMed · Cited by 6
Azad, N., Sakla, N., & Bahn, G. (2018) · Cited by 4
Alidjanov, J. F., Wolf, J., Schuppe, H., Weidner, W., Thorsten Diemer, A., Linn, T., Halefeldt, I., Wagenlehner, F., Wiltink, J., & Pilatz, A. M. E. (2014) · Andrologia · doi:10.1111/and.12215 · Cited by 4
“symptoms are of increasing interest affecting different male patient groups, especially ageing male subjects with late-onset hypogonadism (Reid, 1987; Arver et al., 1999; Dhindsa et al., 2004).”
BackgroundDiabetes and Hypogonadism in Males
Lakshmi, G., & Mahadevan, S. (2025) · Apollo Medicine · doi:10.1177/09760016251332088 · Cited by 5
“[6] More often than not, ED in men with T2DM is not due to testosterone deficiency.”
Diabetes and gonadal disorders
Chen, M., & Dou, J. (2014) · Journal of Translational Internal Medicine · doi:10.4103/2224-4018.141834 · Cited by 4
“Hypogonadism with low gonadotropic hormone was present in more than 1/3 of the male patients with type II diabetes, and the study on 103 patients with an average duration of 7 years of type II diabetes showed that LH and FSH were both signifi cantly reduced in patients with low FT as compared with those in patients wi…”
BackgroundInfluentialSchütz, L. F., Park, M. H., & Choudhury, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812019-4.00035-0 · Cited by 5
Rabijewski, M., Papierska, L., Maksym, R., Tomasiuk, R., Kajdy, A., & Siekierski, B. P. (2018) · American Journal of Men s Health · doi:10.1177/1557988318777926 · Cited by 4
“Cross-sectional studies report that 30%–50% of men with T2DM have lowered TT levels (Dhindsa et al., 2004; Kapoor et al., 2007).”
BackgroundChan, Y. X., Alfonso, H. S., Fegan, P. G., Flicker, L. A., & Yeap, B. B. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01142 · Cited by 4
Niknam, A., Mahboobifard, F., Rahmati, M., Firouzi, F., Rojhani, E., Azizi, F., & Tehrani, F. R. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01225-x · Cited by 5
Recognizing the True Value of Testosterone Therapy in Health Care
Morgentaler, A., Traish, A. M., Barua, R. S., Dandona, P., Dhindsa, S., Khera, M., & Saad, F. (2022) · Androgens Clinical Research and Therapeutics · doi:10.1089/andro.2022.0021 · Cited by 6
“Although more studies are needed to better understand this protective and therapeutic relationship between TTh and prostate cancer, it is now evident that prostate cancer can no longer be considered a risk of TTh. TTh Is a Potentially Valuable Treatment in T2DM In a study of 103 men with T2DM, 33% were found to have T…”
BackgroundSelf-citationOh, J.-H., Choi, J., Kim, D. W., Kim, S., & Garagiola, U. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084316 · Cited by 4
“For this study, an additional 40 testes were obtained from experiments on STZ-not-injected rats (GWNU-2021-21 and was approved on 23 November 2021) that were of the same age as the rats used in this experiment.”
MethodAuthors’ Response: Frequent Occurrence of Hypogonadotropic Hypogonadism in Type 2 Diabetes
Dhindsa, S., Prabhakar, S., & Dandona, P. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2469 · Cited by 5
Self-citationReview: Androgens, erectile dysfunction and cardiovascular risk in type 2 diabetes
Hackett, G. I. (2009) · The British Journal of Diabetes · doi:10.1177/1474651409340361 · Cited by 4
Low testosterone level increases fasting blood glucose level in adult males
Suweino, S., Parwanto, M. E., & Tjahjadi, D. (2012) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.18051/univmed.2012.v31.200-207 · Cited by 4
“(5) Dhindsa et al.(6) reported that 43% of males with type 2 diabetes had low total testosterone levels, with a decrease in 57% of the free testosterone.”
BackgroundAllan, C. A., & McLachlan, R. I. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00139-6 · Cited by 7
Sexual Dysfunction in Asian Males with Type 2 Diabetes Mellitus
Venggadasamy, V., Ho, L. S., Ahmad, B., & Kadir, K. A. (2021) · Progress In Microbes & Molecular Biology · doi:10.36877/pmmb.a0000259 · Cited by 4
“It is still uncertain if hypogonadotropic hypogonadism, a common occurrence in diabetic men, contributes to ED([14,15]).”
BackgroundClinical Evaluation of Leydig Cell Function
Swerdloff, R. S., & Wang, C. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-453-7_30 · Cited by 4
Ho, C., Yu, H., Wang, C., Jaw, F., Hsieh, J., Liao, W.-C., Pu, Y., & Liu, S. (2013) · PLoS ONE · doi:10.1371/annotation/c226aa64-8d3b-4c29-971b-84f87b618291 · Cited by 4
Hypogonadotropic Hypogonadism in Diabesity: Pathogenic Factors and Therapeutic Implications
Dandona, P., Dhindsa, S., & Ghanim, H. (2022) · Androgens Clinical Research and Therapeutics · doi:10.1089/andro.2022.0019 · Cited by 4
“Hypogonadotropic hypogonadism (HH) was found to occur in 33% male patients with type 2 diabetes.(1) These patients had low total and free testosterone concentrations with inappropriately low or normal luteinizing hormone (LH) and follicle-stimulating hormone (FSH) concentrations.”
BackgroundSelf-citationMale Hypogonadism (According to the Materials of the European Association of Urology)
Gorpynchenko, I., Gurzhenko, Y., & Spyrydonenko, V. (2022) · Health of Man · doi:10.30841/2307-5090.4.2022.274432 · Cited by 3
Genchi, V. A., Zanni, E., Colzani, M., Lauriola, C., Cignarelli, A., Santi, D., & Greco, C. (2023) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2023.06 · Cited by 4
Low Testosterone in Men With Type 2 Diabetes: The Role of Estrogen Excess and Aromatase Activity
Tun, N. N., Livingstone, D. E. W., & Gibb, F. W. (2026) · Clinical Endocrinology · doi:10.1111/cen.70098 · Cited by 3
Zafrani, Z., Khan, S. S., & Zitzmann, M. (2026) · Cells · doi:10.3390/cells15151319 · Cited by 3
“These findings align with earlier epidemiological and mechanistic studies linking metabolic dysfunction to suppression of testosterone production [1,2,5].”
Castro, M. A., Mariño‐Sánchez, F., Fernández, A. G., Cancela, A. A., & Berrocal, V. R. (2022) · Neurocirugía (English Edition) · doi:10.1016/j.neucie.2021.07.002 · Cited by 3
Sokol, R. Z. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511635656.013 · Cited by 4
Testosterone, the metabolic syndrome and diabetes mellitus
Heufelder, A. E. (2008) · Journal of Men s Health · doi:10.1016/j.jomh.2008.03.013 · Cited by 5
“Somewhat surprisingly, the nature of the hypogonadism associated with diabetes mellitus type 2 appears to be hypogonadotropic [26].”
Stem Cell Treatment for Complicated Diabetes
Bahk, J. Y., Han, H. J., & Lee, Y. S. (2008) · International Journal of Stem Cells · doi:10.15283/ijsc.2008.1.1.91 · Cited by 3
“About one-third of type 2 diabetic men have lower levels of free testosterone (4).”
BackgroundEffect of Type2 Diabetes Mellitus on Sudanese Male Fertility
Mohieldin, J. M., Mohammed, N. B., & Abdalla, O. M. (2016) · Scholars Journal of Applied Medical Sciences · doi:10.21276/sjams.2016.4.6.72 · Cited by 6
“This is the same as mentioned by Dhinds et al [11] they reported that their patients were markedly more hypogonadal in all age groups from 40–70 years.”
BackgroundMethodResultInfluentialDefeudis, G., Maddaloni, E., Rossini, G., Tommaso, A. D. D., Mazzilli, R., Palma, P. D., Pozzilli, P., & Napoli, N. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11185333 · Cited by 3
Prevalence of Erectile Dysfunction in Men with Type 2 Diabetes Mellitus in Osun State, Nigeria
Airaodion, A. I., Ijioma, C. E., Ejikem, P. I., Abali, I. O., Aminu-Ayinde, O. E., Ogwu, C. I., Kalesanwo, E. A., Amuta, A. C., Areh, J. E., Odarah, J. E., et al. (2023) · Direct Research Journal of Health and Pharmacology · doi:10.26765/drjhp20198426375 · Cited by 6
Testostérone plasmatique, obésité, syndrome métabolique et diabète
Prévost, G., Eas, F., & Kuhn, J. (2013) · La Presse Médicale · doi:10.1016/j.lpm.2013.04.023 · Cited by 4
“Il a été montré que le taux de testostérone plasmatique était fréquemment plus bas dans la population d’hommes atteints d’insulino-résistance que dans une population du même âge indemne de pathologie quelconque [2,7,8].”
BackgroundInfluentialAge-Related Androgen Deficiency and Type 2 Diabetes
Ryan, G. J., & Jobe, L. J. (2011) · Journal of Pharmacy Practice · doi:10.1177/0897190010397719 · Cited by 3
“Obesity can lead to hypogonadism by increasing aromatization of testosterone to estradiol (much of which occurs in adipose tissue) and/or derangements in the hypothalamic-pituitary-adrenal-testicular axis.17 Hyperinsulinemia and obesity also seem to be associated with decreased SHBG production,16,18-20 and patients wi…”
BackgroundInfluentialAlmihy, N., Eissa, E. A., Amer, E., & Elassal, M. (2015) · Benha Medical Journal · doi:10.4103/1110-208x.170556 · Cited by 4
Mancini, A., Raimondo, S., Segni, C. D., Gadotti, G., Giacchi, E., Zollino, M., Bonomi, M., Persani, L., & Pontecorvi, A. (2014) · Cited by 3
Kharazi, U., Keyhanmanesh, ., Hamidian, G., Ghaderpour, S., & Ghiasi, R. (2021) · PubMed Central · doi:10.22038/ijbms.2021.58740.13048 · Cited by 3
Li, H., Kong, X., Zhang, H., & Wu, J. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01876.x · Cited by 3
Zenaw, A., Chane, E., Fetene, G., Baynes, H. W., Mekuanint, A., Kinde, Y., Kassie, T., Demeke, K., Fasil, A., & Worede, A. (2025) · PLoS ONE · doi:10.1371/journal.pone.0329784 · Cited by 3
“This is due to aging reduces outflow of GnRH and the efficacy of endogenous LH-mediated testosterone secretion [43,44].”
Effect of Incretin-Based Weight Loss Drugs on Testosterone Concentrations in Men
Canales, S. P., Iqbal, I., Akande, R. O., Ghimire, A., Kalishman, A. J., Wood, E. M., Albert, S. G., & Dhindsa, S. (2026) · Endocrine Practice · doi:10.1016/j.eprac.2026.01.003 · Cited by 3
Self-citationGonadal Function in Male Mountain Bikers
Yamaner, F., Atmaca, H., Bayraktaroğlu, T., Aydın, M., & Aydemir, S. (2011) · The Journal of Strength and Conditioning Research · doi:10.1519/jsc.0b013e3181f6b0dd · Cited by 2
“Namely, low testosterone levels are associated with insulin resistance (8,26).”
BackgroundValoración de niveles de testosterona mediante diferentes métodos analíticos en varones sanos
Pérez, C. S., & Pérez, J. Á. D. (2010) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2010.04.006 · Cited by 2
Benefits and Risks of Testosterone Therapy in Men With Testosterone Deficiency
Traish, A. M., & Morgentaler, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813197-8.00018-x · Cited by 2
Luchytskyi, V. Y., Tronko, M. D., & Luchytskyy, Y. V. (2019) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.15.2.2019.166099 · Cited by 2
Environmental Factors’ Interference in Endocrine Aspects of Male Reproduction
Pivonello, C., de Angelis, C., Garifalos, F., Pivonello, R., & Colao, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-35213-4_3 · Cited by 2
Ajao, F. O. (2023) · Journal of Applied Pharmaceutical Sciences and Research · doi:10.31069/japsr.v6i1.03 · Cited by 2
Grossmann, M., & Wittert, G. (2024) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15188 · Cited by 3
Anti-Obesity Effects of Androgens, Dehydroepiandrosterone (DHEA) and Testosterone
Kajita, K., Mori, I., Yamauchi, M., Ikeda, T., Morita, H., & Ishizuka, T. (2015) · InTech eBooks · doi:10.5772/59604 · Cited by 2
“Low free testosterone is correlated positively with LH in diabetic men, and therefore, hypogonadotropic hypogonadism is common in these patients [34].”
BackgroundPrevalence of Hypogonadism in a Male Population below 60 Years of Age with Metabolic Syndrome
Ríos, R., Jara, N., Ratkman, B., Valenzuela, A., Palavecino, C., & Ortuya, J. M. (2015) · Advances in Andrology · doi:10.1155/2015/613259 · Cited by 2
Georgescu, O., Reghina, A. D., Ioacără, S., Nica, C., & Fica, S. V. (2013) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/rjdnmd-2013-0040 · Cited by 3
“related decrease in men testosterone level is exacerbated by diabetes also [4,5].”
Metabolic syndrome in men with sexual dysfunction
Talukder, S. K., Afsana, F., & Khan, S. J. (2010) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2010.07.001 · Cited by 2
Evidence of male hypogonadism at an early age as a familial risk of type 2 diabetes
Janjua, Q. M., Shahid, A., Alam, R., Rizwan, M., Saeed, S., Qazi, M. H., & Arslan, M. (2015) · Annales d Endocrinologie · doi:10.1016/j.ando.2015.10.005 · Cited by 2
Age-Related Testosterone Decline: Whom Do We Treat and Why?
Ahmad, A. E., Bruha, M., & Welliver, C. (2016) · Current Sexual Health Reports · doi:10.1007/s11930-016-0074-1 · Cited by 2
Morgentaler, A., Zitzmann, M., Traish, A. M., Fox, A. W., Jones, T. H., Maggi, M., Arver, S., Aversa, A., Chan, J. C. N., Dobs, A. S., et al. (2016) · Obesity and metabolism · doi:10.14341/omet2016315-31 · Cited by 2
(2015) · Endocrinology & Metabolic Syndrome · doi:10.4172/2161-1017.1000162 · Cited by 4
“7% prevalence of low testosterone levels in 103 men with T2D [12].”
BackgroundResultChuang, S., Lee, C., Chien, M.-N., Sun, F., & Wang, C. (2017) · International journal of gerontology · doi:10.1016/j.ijge.2016.12.001 · Cited by 2
Pituitary Evaluation in Patients with Low Prostate-Specific Antigen
Drincic, A., Nguyen, A.-T., Singh, S., Zena, M., Walters, R. W., Friedman, K., & Anderson, R. J. (2018) · Endocrine Practice · doi:10.4158/ep-2018-0204 · Cited by 2
Narcolepsy, depression, and severe flushing in an obese man
Biobaku, F., Hanna, A., Matthews, G. E., Dhindsa, S., & Dandona, P. (2020) · Clinical Case Reports · doi:10.1002/ccr3.2873 · Cited by 2
Self-citationAlhammer, A. H. (2015) · Journal of Biotechnology Research Center · doi:10.24126/jobrc.2015.9.1.391 · Cited by 3
Age-Related Testosterone Deficiency Merits Treatment
Traish, A. M. (2021) · Androgens Clinical Research and Therapeutics · doi:10.1089/andro.2020.0019 · Cited by 4
Nakayama, A., Morita, H., Kawahara, T., Itoh, H., & Komuro, I. (2021) · Heart and Vessels · doi:10.1007/s00380-021-01872-5 · Cited by 2
Gamidov, S. I., Тажетдинов, О. Х., Pavlovichev, A., Попова, А. Ю., & Тхагапсоева, Р. А. (2010) · Problems of Endocrinology · doi:10.14341/probl201056533-42 · Cited by 3
The Application of 4-Hexylresorcinol for Preventing Diabetic Complications
Kim, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-0637-2_8 · Cited by 2
SEX HORMONE BINDING GLOBULIN GENE POLYMORPHISM AND RISK OF TYPE2 DIABETES MELLITUS IN EGYPTIAN MEN
Tarhouny, S. E., Zakaria, S. S., Hadhoud, K. M., Hanafi, M. I., Kamel, A., & Nozha, O. A. (2014) · Zagazig University Medical Journal · doi:10.21608/zumj.2014.4339 · Cited by 1
Abichandani, V. K., & Kalhan, A. (2023) · Chronicle of Diabetes Research and Practice · doi:10.4103/cdrp.cdrp_cdrp_20_22 · Cited by 1
Metadata
- Authors
- Dhindsa, S., Prabhakar, S., Sethi, M., Bandyopadhyay, A., Chaudhuri, A., & Dandona, P.
- Affiliations
- Kaleida Health (US)
- Corresponding author
- Dandona, Paresh
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-11
- Volume
- 89
- Issue
- 11
- Pages
- 5462-5468
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2161417745
- Semantic Scholar
- 7eedeed5e563a3df27e91e79ee34ce6e496a93e3
- Cited by
- 631
- References
- 44
- Citations by year
- 2026: 18 · 2025: 16 · 2024: 17 · 2023: 14 · 2022: 24 · 2021: 37 · 2020: 19 · 2019: 27 · 2018: 40 · 2017: 36 · 2016: 37 · 2015: 36 · 2014: 42 · 2013: 43 · 2012: 38
- FWCI
- 9.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- type 2 diabetes, testosterone, free testosterone, sex hormone-binding globulin, luteinizing hormone, follicle-stimulating hormone, prolactin, body mass index, prevalence, hyperandrogenism, insulin resistance, HbA1c
- MeSH terms
- Adult, Age Factors, Aged, Aged, 80 and over, Diabetes Mellitus, Type 2, Follicle Stimulating Hormone, Humans, Hypogonadism, Luteinizing Hormone, Male, Middle Aged, Sex Hormone-Binding Globulin, Testosterone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.